115 related articles for article (PubMed ID: 9179261)
1. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S
J Surg Oncol; 1997 May; 65(1):10-9. PubMed ID: 9179261
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D as a potential prognostic marker for lung adenocarcinoma.
Mimae T; Tsuta K; Maeshima AM; Okada M; Asamura H; Kondo T; Tsuda H
Pathol Res Pract; 2012 Sep; 208(9):534-40. PubMed ID: 22824147
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma.
Theodoropoulos GE; Panoussopoulos D; Lazaris AC; Golematis BC
J Surg Oncol; 1997 Aug; 65(4):242-8. PubMed ID: 9274788
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth.
Rapa I; Volante M; Cappia S; Rosas R; Scagliotti GV; Papotti M
Am J Clin Pathol; 2006 Jun; 125(6):847-54. PubMed ID: 16690483
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
7. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
8. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical assessment of cathepsin D in gastric carcinoma: its impact on clinical prognosis.
Allgayer H; Babic R; Grützner KU; Beyer BC; Tarabichi A; Wilhelm Schildberg F; Heiss MM
Cancer; 1997 Jul; 80(2):179-87. PubMed ID: 9217027
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of cathepsin D expression in non-small cell lung cancer is conditional on apoptosis-associated protein phenotype: an immunohistochemistry study.
Fan C; Lin X; Wang E
Tumour Biol; 2012 Aug; 33(4):1045-52. PubMed ID: 22302483
[TBL] [Abstract][Full Text] [Related]
11. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
14. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer.
Lösch A; Tempfer C; Kohlberger P; Joura EA; Denk M; Zajic B; Breitenecker G; Kainz C
Br J Cancer; 1998 Jul; 78(2):205-9. PubMed ID: 9683294
[TBL] [Abstract][Full Text] [Related]
16. Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
Lösch A; Kohlberger P; Gitsch G; Kaider A; Breitenecker G; Kainz C
Br J Cancer; 1996 Jun; 73(12):1525-8. PubMed ID: 8664123
[TBL] [Abstract][Full Text] [Related]
17. Diverse prognostic roles of Akt isoforms, PTEN and PI3K in tumor epithelial cells and stromal compartment in non-small cell lung cancer.
Al-Saad S; Donnem T; Al-Shibli K; Persson M; Bremnes RM; Busund LT
Anticancer Res; 2009 Oct; 29(10):4175-83. PubMed ID: 19846969
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G; Titius BR
J Clin Pathol; 1996 Jan; 49(1):57-64. PubMed ID: 8666688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
